Dr. Slingerland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1611 NW 12th Ave
Box 016960 M851
Miami, FL 33136Phone+1 305-585-1111Fax+1 305-243-9927
Education & Training
- University of Toronto Faculty of MedicineClass of 1983
Certifications & Licensure
- DC State Medical License 2021 - 2024
- FL State Medical License 2002 - 2022
- OH State Medical License 2016 - 2018
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Elected Member The American Society for Clinical Investigation, 2002
- Super Doctor SuperDoctors.com
Clinical Trials
Publications & Presentations
PubMed
- 133 citationsInteractions between Adipocytes and Breast Cancer Cells Stimulate Cytokine Production and Drive Src/Sox2/miR-302b–Mediated Malignant ProgressionManuel Picon-Ruiz, Chendong Pan, Katherine Drews-Elger, Kibeom Jang, Alexandra H. Besser
Cancer Research. 2016-01-15 - 73 citationsp27 as a Transcriptional Regulator: New Roles in Development and Cancer.Seyedeh Fatemeh Razavipour, Kuzhuvelil B. Harikumar, Joyce M. Slingerland
Cancer Research. 2020-09-01 - 19 citationsDOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer.Hetakshi Kurani, Seyedeh Fatemeh Razavipour, Kuzhuvelil B Harikumar, Matthew Dunworth, Andrew J Ewald
Clinical Cancer Research. 2022-05-02
Press Mentions
- Breast Cancer Is Increasingly Being Linked to ObesityOctober 13th, 2018
- They Were Thought to Be ‘Too Young’ to Have Breast Cancer. They Were WrongOctober 12th, 2018
- Polycomb Complexes Associate with Enhancers and Promote Oncogenic Transcriptional Programs in Cancer Through Multiple MechanismsAugust 23rd, 2018
- Join now to see all
Grant Support
- Effects Of The PI3K Pathway On P27 Function And Cancer ProgressionNational Cancer Institute2010–2012
- Mechanisms Whereby SRC Activates Estrogen Stimulated ER Proteolysis And ER TargetNational Cancer Institute2009–2012
- Training In Translational Breast Cancer ResearchNational Cancer Institute2007–2011
- A Neoadjuvant Trial Of Anastrazole And A Novel SRC Inhibitor, Azd0530, For LabcNational Cancer Institute2009–2010
- PI3K Opposes P27 And G1 Arrest By Tgf-B In Human CancerNational Cancer Institute2004–2007
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: